Raj Kannan

Chief Executive Officer, Chiasma (United States).

Companies

Aerie PharmaceuticalsBoard member Dec 22, 2021 to Nov 21, 2022¹
Aerie PharmaceuticalsChief executive officer Dec 22, 2021 to Nov 21, 2022¹
Chiasma (United States)President Feb 11, 2021 to Aug 5, 2021²
Chiasma (United States)Board member Jun 17, 2019 to Aug 5, 2021³
Chiasma (United States)Chief executive officer Jun 17, 2019 to Aug 5, 2021³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Aerie Pharmaceuticals AERI0 shares⁴Nov 21, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Nov 21, 2022Returned to company 215,783 shares at $15.25 of Aerie Pharmaceuticals⁴
Dec 20, 2021Granted 215,783 shares of Aerie Pharmaceuticals⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAerie Pharmaceuticals, Board member
2
SEC EDGARChiasma (United States), President
3
SEC EDGARChiasma (United States), Board member
4
SEC EDGARAerie Pharmaceuticals shares after the filing of Nov 21, 2022
5
SEC EDGARForm 4 filed Dec 22, 2021